|Bid||0.8810 x 1000|
|Ask||0.9400 x 1100|
|Day's range||0.8810 - 0.9950|
|52-week range||0.7500 - 1.9300|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||N/A|
|Earnings date||07 Feb 2024 - 12 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.50|
ADT (ADT) delivered earnings and revenue surprises of -30.43% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
STONY BROOK, N.Y., May 03, 2023--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. ET.
STONY BROOK, N.Y., April 07, 2023--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in PCR-based DNA technologies, announced that its CertainT® supply chain traceability platform is featured in an article on the home page of the New York Times website today. The article, titled "How A.I. and DNA Are Unlocking the Mysteries of Global Supply Chains," centers on the mounting need for the textile and other industries to employ tracing technologies to ensure compliance with the Uyg